Navigating regulatory change, overseeing the deployment of AI in healthcare organizations, and preventing and detecting healthcare fraud were among the topics discussed by industry participants, regulators and service providers gathered in Washington, DC, last week at the 26th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress (PCC).
Speakers pointed
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day
